Company / Revenue per Share
Glaukos Corp. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$8.99
FY2025
5-year range
$6.02 / $8.99
FY2021-FY2025
Trend
+15.2%
vs FY2024
Sector context
#115 of 147
Health Care
What the data says
Glaukos Corp.'s revenue per share of $8.99 is lower than 78% of companies in the Health Care sector (FY2025). Revenue per Share has increased for 3 consecutive years, from $6.02 in FY2022 to $8.99 in FY2025.
Based on SEC 10-K filings.
8.99 in FY2025 with a 5-year CAGR of +11.7%.
Improved from $6.59 to $8.99 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +14.3%
- 5-Year CAGR
- +11.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 22% in Health CareTop 78% of 147This company $8.99 Sector average $127.83
▼
-93.0% below sector average
Key checks
Key Insights
- Glaukos Corp.'s revenue per share has grown for 3 consecutive years.
- In FY2025, revenue per share increased 15.2% year-over-year.
- Ranks #115 out of 147 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.99 | +15.2% |
| FY2024 | $7.81 | +18.5% |
| FY2023 | $6.59 | +9.4% |
| FY2022 | $6.02 | -7.3% |
| FY2021 | $6.50 | +25.7% |
| FY2020 | $5.17 | -21.2% |
| FY2019 | $6.56 | +25.3% |
| FY2018 | $5.24 | +11.6% |
| FY2017 | $4.69 | +32.0% |
| FY2016 | $3.55 | -87.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026